Welcome!

News Feed Item

Acute Heart Failure Global Clinical Trials Review, H2, 2014

NEW YORK, Sept. 2, 2014 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue:

Acute Heart Failure Global Clinical Trials Review, H2, 2014

http://www.reportlinker.com/p0689743/Acute-Heart-Failure-Global-Clinical-Trials-Review-H2-2014.html

Acute Heart Failure Global Clinical Trials Review, H2, 2014

Summary

GlobalData's clinical trial report, "Acute Heart Failure Global Clinical Trials Review, H2, 2014" provides data on the Acute Heart Failure clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Acute Heart Failure. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Acute Heart Failure. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each, along with the clinical trial scenario in BRIC nations
- Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type
- Listings of discontinued trials (suspended, withdrawn and terminated)

Reasons to buy

- Understand the dynamics of a particular indication in a condensed manner
- Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more
- Obtain discontinued trial listing for trials across the globe
- Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies
Table of Contents
Table of Contents 2

Introduction 6
Acute Heart Failure 6
Report Guidance 6
Clinical Trials by Region 7
Clinical Trials and Average Enrollment by Country 8
Top Five Countries Contributing to Clinical Trials in Asia-Pacific 10
Top Five Countries Contributing to Clinical Trials in Europe 11
Top Countries Contributing to Clinical Trials in North America 12
Top Five Countries Contributing to Clinical Trials in Middle East and Africa 13
Top Countries Contributing to Clinical Trials in Central and South America 14
Clinical Trials by G7 Countries: Proportion of Acute Heart Failure to Cardiovascular Clinical Trials 15
Clinical Trials by Phase in G7 Countries 16
Clinical Trials in G7 Countries by Trial Status 17
Clinical Trials by E7 Countries: Proportion of Acute Heart Failure to Cardiovascular Clinical Trials 18
Clinical Trials by Phase in E7 Countries 19
Clinical Trials in E7 Countries by Trial Status 20
Clinical Trials by Phase 21
In Progress Trials by Phase 22
Clinical Trials by Trial Status 23
Clinical Trials by End Point Status 24
Unaccomplished Trials of Acute Heart Failure 25
Subjects Recruited Over a Period of Time 28
Clinical Trials by Sponsor Type 29

Prominent Sponsors 30
Top Companies Participating in Acute Heart Failure Therapeutics Clinical Trials 31
Prominent Drugs 32
Latest Clinical Trials News on Acute Heart Failure 33
Jul 28, 2014: Cardioxyl Pharmaceuticals Successfully Completes First Clinical Trial For Heart Failure Drug CXL-1427 33
Clinical Trial Profiles 34
Clinical Trial Overview of Top Companies 34
Novartis AG 34
Clinical Trial Overview of Novartis AG 34
Nile Therapeutics, Inc. 35
Clinical Trial Overview of Nile Therapeutics, Inc. 35
Cardiorentis AG 36
Clinical Trial Overview of Cardiorentis AG 36
Amgen Inc. 37
Clinical Trial Overview of Amgen Inc. 37
Abbott Laboratories 38
Clinical Trial Overview of Abbott Laboratories 38
Cytokinetics, Inc. 39
Clinical Trial Overview of Cytokinetics, Inc. 39
Biogen Idec Inc. 40
Clinical Trial Overview of Biogen Idec Inc. 40
Bayer AG 41
Clinical Trial Overview of Bayer AG 41
Alere Inc. 42
Clinical Trial Overview of Alere Inc. 42

Actelion Ltd 43
Clinical Trial Overview of Actelion Ltd 43
Clinical Trial Overview of Top Institutes / Government 44
Duke University 44
Clinical Trial Overview of Duke University 44
National Cerebral and Cardiovascular Center 45
Clinical Trial Overview of National Cerebral and Cardiovascular Center 45
University Hospital Basel 46
Clinical Trial Overview of University Hospital Basel 46
Assistance Publique - Hopitaux de Paris 47
Clinical Trial Overview of Assistance Publique - Hopitaux de Paris 47
French Cardiology Society 48
Clinical Trial Overview of French Cardiology Society 48
Northwestern University 49
Clinical Trial Overview of Northwestern University 49
University Hospital of Larissa 50
Clinical Trial Overview of University Hospital of Larissa 50
The Cleveland Clinic 51
Clinical Trial Overview of The Cleveland Clinic 51
Hebei Medical University 52
Clinical Trial Overview of Hebei Medical University 52
YAMAGUCHI UNIVERSITY 53
Clinical Trial Overview of YAMAGUCHI UNIVERSITY 53
Five Key Clinical Profiles 54
Appendix 81
Abbreviations 81
Definitions 81
Research Methodology 82
Secondary Research 82
About GlobalData 83
Contact Us 83
Disclaimer 83
Source 83

List of Tables

Acute Heart Failure Therapeutics, Global, Clinical Trials by Region, 2014* 7
Acute Heart Failure Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014* 8
Acute Heart Failure Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014* 9
Acute Heart Failure Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2014* 10
Acute Heart Failure Therapeutics Clinical Trials, Europe, Top Five Countries, 2014* 11
Acute Heart Failure Therapeutics Clinical Trials, North America, Top Countries, 2014* 12
Acute Heart Failure Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries, 2014* 13
Acute Heart Failure Therapeutics Clinical Trials, Central and South America, Top Countries, 2014* 14
Proportion of Acute Heart Failure to Cardiovascular Clinical Trials, G7 Countries (%), 2014* 15
Acute Heart Failure Therapeutics, G7 Countries, Clinical Trials by Phase, 2014* 16
Acute Heart Failure Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014* 17
Proportion of Acute Heart Failure to Cardiovascular Clinical Trials, E7 Countries (%), 2014* 18
Acute Heart Failure Therapeutics, E7 Countries, Clinical Trials by Phase, 2014* 19
Acute Heart Failure Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2014* 20
Acute Heart Failure Therapeutics, Global, Clinical Trials by Phase, 2014* 21
Acute Heart Failure Therapeutics, Global, Clinical Trials In Progress by Phase 2014* 22
Acute Heart Failure Therapeutics, Global, Clinical Trials by Trial Status, 2014* 23

Acute Heart Failure Therapeutics Clinical Trials, Global, by End Point Status, 2014* 24
Acute Heart Failure Therapeutics, Global, Withdrawn Clinical Trials, 2014* 25
Acute Heart Failure Therapeutics, Global, Terminated Clinical Trials, 2014* 26
Acute Heart Failure Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013 28
Acute Heart Failure Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2014* 29
Acute Heart Failure Therapeutics Clinical Trials, Global, Key Sponsors, 2014* 30
Acute Heart Failure Therapeutics Clinical Trials, Global, Top Companies by Phase, 2014* 31
Acute Heart Failure Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014* 32
Acute Heart Failure Therapeutics Clinical Trials Market, Global, Clinical Trials by Novartis AG, 2014* 34
Acute Heart Failure Therapeutics Clinical Trials Market, Global, Clinical Trials by Nile Therapeutics, Inc., 2014* 35
Acute Heart Failure Therapeutics Clinical Trials Market, Global, Clinical Trials by Cardiorentis AG, 2014* 36

Acute Heart Failure Therapeutics Clinical Trials Market, Global, Clinical Trials by Amgen Inc., 2014* 37
Acute Heart Failure Therapeutics Clinical Trials Market, Global, Clinical Trials by Abbott Laboratories, 2014* 38
Acute Heart Failure Therapeutics Clinical Trials Market, Global, Clinical Trials by Cytokinetics, Inc., 2014* 39
Acute Heart Failure Therapeutics Clinical Trials Market, Global, Clinical Trials by Biogen Idec Inc., 2014* 40
Acute Heart Failure Therapeutics Clinical Trials Market, Global, Clinical Trials by Bayer AG, 2014* 41
Acute Heart Failure Therapeutics Clinical Trials Market, Global, Clinical Trials by Alere Inc., 2014* 42
Acute Heart Failure Therapeutics Clinical Trials Market, Global, Clinical Trials by Actelion Ltd, 2014* 43
Acute Heart Failure Therapeutics Clinical Trials Market, Global, Clinical Trials by Duke University, 2014* 44
Acute Heart Failure Therapeutics Clinical Trials Market, Global, Clinical Trials by National Cerebral and Cardiovascular Center, 2014* 45
Acute Heart Failure Therapeutics Clinical Trials Market, Global, Clinical Trials by University Hospital Basel, 2014* 46
Acute Heart Failure Therapeutics Clinical Trials Market, Global, Clinical Trials by Assistance Publique - Hopitaux de Paris, 2014* 47
Acute Heart Failure Therapeutics Clinical Trials Market, Global, Clinical Trials by French Cardiology Society, 2014* 48
Acute Heart Failure Therapeutics Clinical Trials Market, Global, Clinical Trials by Northwestern University, 2014* 49
Acute Heart Failure Therapeutics Clinical Trials Market, Global, Clinical Trials by University Hospital of Larissa, 2014* 50
Acute Heart Failure Therapeutics Clinical Trials Market, Global, Clinical Trials by The Cleveland Clinic, 2014* 51
Acute Heart Failure Therapeutics Clinical Trials Market, Global, Clinical Trials by Hebei Medical University, 2014* 52
Acute Heart Failure Therapeutics Clinical Trials Market, Global, Clinical Trials by YAMAGUCHI UNIVERSITY, 2014* 53

List of Figures

Acute Heart Failure Therapeutics, Global, Clinical Trials by Region (%), 2014* 7
Acute Heart Failure Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014* 8
Acute Heart Failure Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014* 9
Acute Heart Failure Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2014* 10
Acute Heart Failure Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2014* 11
Acute Heart Failure Therapeutics Clinical Trials, North America, Top Countries (%), 2014* 12
Acute Heart Failure Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries (%), 2014* 13
Acute Heart Failure Therapeutics Clinical Trials, Central and South America, Top Countries (%), 2014* 14
Proportion of Acute Heart Failure to Cardiovascular Clinical Trials, G7 Countries (%), 2014* 15
Acute Heart Failure Therapeutics, G7 Countries, Clinical Trials by Phase, 2014* 16
Acute Heart Failure Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014* 17
Proportion of Acute Heart Failure to Cardiovascular Clinical Trials, E7 Countries (%), 2014* 18
Acute Heart Failure Therapeutics, E7 Countries, Clinical Trials by Phase, 2014* 19
Acute Heart Failure Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2014* 20
Acute Heart Failure Therapeutics, Global, Clinical Trials by Phase (%), 2014* 21
Acute Heart Failure Therapeutics, Global, Clinical Trials In Progress by Phase, 2014* 22
Acute Heart Failure Therapeutics, Global, Clinical Trials by Trial Status, 2014* 23
Acute Heart Failure Therapeutics Clinical Trials, Global, by End Point Status, 2014* 24
Acute Heart Failure Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013 28
Acute Heart Failure Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2014* 29
Acute Heart Failure Therapeutics Clinical Trials, Global, Key Sponsors, 2014* 30
Acute Heart Failure Therapeutics Clinical Trials, Global, Top Companies by Phase, 2014* 31
Acute Heart Failure Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014* 32
GlobalData Methodology 82

To order this report: Acute Heart Failure Global Clinical Trials Review, H2, 2014
http://www.reportlinker.com/p0689743/Acute-Heart-Failure-Global-Clinical-Trials-Review-H2-2014.html

__________________________
Contact Clare: clare@reportlinker.com
US: (339)-368-6001
Intl: +1 339-368-6001

SOURCE Reportlinker

More Stories By PR Newswire

Copyright © 2007 PR Newswire. All rights reserved. Republication or redistribution of PRNewswire content is expressly prohibited without the prior written consent of PRNewswire. PRNewswire shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon.

Latest Stories
The explosion of new web/cloud/IoT-based applications and the data they generate are transforming our world right before our eyes. In this rush to adopt these new technologies, organizations are often ignoring fundamental questions concerning who owns the data and failing to ask for permission to conduct invasive surveillance of their customers. Organizations that are not transparent about how their systems gather data telemetry without offering shared data ownership risk product rejection, regu...
Information technology (IT) advances are transforming the way we innovate in business, thereby disrupting the old guard and their predictable status-quo. It’s creating global market turbulence. Industries are converging, and new opportunities and threats are emerging, like never before. So, how are savvy chief information officers (CIOs) leading this transition? Back in 2015, the IBM Institute for Business Value conducted a market study that included the findings from over 1,800 CIO interviews ...
Who are you? How do you introduce yourself? Do you use a name, or do you greet a friend by the last four digits of his social security number? Assuming you don’t, why are we content to associate our identity with 10 random digits assigned by our phone company? Identity is an issue that affects everyone, but as individuals we don’t spend a lot of time thinking about it. In his session at @ThingsExpo, Ben Klang, Founder & President of Mojo Lingo, discussed the impact of technology on identity. Sho...
@DevOpsSummit has been named the ‘Top DevOps Influencer' by iTrend. iTrend processes millions of conversations, tweets, interactions, news articles, press releases, blog posts - and extract meaning form them and analyzes mobile and desktop software platforms used to communicate, various metadata (such as geo location), and automation tools. In overall placement, @DevOpsSummit ranked as the number one ‘DevOps Influencer' followed by @CloudExpo at third, and @MicroservicesE at 24th.
SYS-CON Events announced today that Enzu will exhibit at SYS-CON's 20th International Cloud Expo®, which will take place on June 6-8, 2017, at the Javits Center in New York City, NY, and the 21st International Cloud Expo®, which will take place October 31-November 2, 2017, at the Santa Clara Convention Center in Santa Clara, CA. Enzu’s mission is to be the leading provider of enterprise cloud solutions worldwide. Enzu enables online businesses to use its IT infrastructure to their competitive ad...
There are 66 million network cameras capturing terabytes of data. How did factories in Japan improve physical security at the facilities and improve employee productivity? Edge Computing reduces possible kilobytes of data collected per second to only a few kilobytes of data transmitted to the public cloud every day. Data is aggregated and analyzed close to sensors so only intelligent results need to be transmitted to the cloud. Non-essential data is recycled to optimize storage.
In his keynote at @ThingsExpo, Chris Matthieu, Director of IoT Engineering at Citrix and co-founder and CTO of Octoblu, focused on building an IoT platform and company. He provided a behind-the-scenes look at Octoblu’s platform, business, and pivots along the way (including the Citrix acquisition of Octoblu).
WebRTC is the future of browser-to-browser communications, and continues to make inroads into the traditional, difficult, plug-in web communications world. The 6th WebRTC Summit continues our tradition of delivering the latest and greatest presentations within the world of WebRTC. Topics include voice calling, video chat, P2P file sharing, and use cases that have already leveraged the power and convenience of WebRTC.
Stratoscale, the software company developing the next generation data center operating system, exhibited at SYS-CON's 18th International Cloud Expo®, which took place at the Javits Center in New York City, NY, in June 2016.Stratoscale is revolutionizing the data center with a zero-to-cloud-in-minutes solution. With Stratoscale’s hardware-agnostic, Software Defined Data Center (SDDC) solution to store everything, run anything and scale everywhere, IT is empowered to take control of their data ce...
In his session at @DevOpsSummit at 19th Cloud Expo, Robert Doyle, lead architect at eCube Systems, will examine the issues and need for an agile infrastructure and show the advantages of capturing developer knowledge in an exportable file for migration into production. He will introduce the use of NXTmonitor, a next-generation DevOps tool that captures application environments, dependencies and start/stop procedures in a portable configuration file with an easy-to-use GUI. In addition to captur...
In his keynote at 18th Cloud Expo, Andrew Keys, Co-Founder of ConsenSys Enterprise, provided an overview of the evolution of the Internet and the Database and the future of their combination – the Blockchain. Andrew Keys is Co-Founder of ConsenSys Enterprise. He comes to ConsenSys Enterprise with capital markets, technology and entrepreneurial experience. Previously, he worked for UBS investment bank in equities analysis. Later, he was responsible for the creation and distribution of life settle...
SYS-CON Events announced today that SD Times | BZ Media has been named “Media Sponsor” of SYS-CON's 20th International Cloud Expo, which will take place on June 6–8, 2017, at the Javits Center in New York City, NY. BZ Media LLC is a high-tech media company that produces technical conferences and expositions, and publishes a magazine, newsletters and websites in the software development, SharePoint, mobile development and commercial UAV markets.
DevOps is being widely accepted (if not fully adopted) as essential in enterprise IT. But as Enterprise DevOps gains maturity, expands scope, and increases velocity, the need for data-driven decisions across teams becomes more acute. DevOps teams in any modern business must wrangle the ‘digital exhaust’ from the delivery toolchain, "pervasive" and "cognitive" computing, APIs and services, mobile devices and applications, the Internet of Things, and now even blockchain.
In the first article of this three-part series on hybrid cloud security, we discussed the Shared Responsibility Model and examined how the most common attack strategies persist, are amplified, or are mitigated as assets move from data centers to the cloud. Today, we’ll look at some of the unique security challenges that are introduced by public cloud environments. While cloud computing delivers many operational, cost-saving and security benefits, it takes place in a public, shared and on-demand ...
Both SaaS vendors and SaaS buyers are going “all-in” to hyperscale IaaS platforms such as AWS, which is disrupting the SaaS value proposition. Why should the enterprise SaaS consumer pay for the SaaS service if their data is resident in adjacent AWS S3 buckets? If both SaaS sellers and buyers are using the same cloud tools, automation and pay-per-transaction model offered by IaaS platforms, then why not host the “shrink-wrapped” software in the customers’ cloud? Further, serverless computing, cl...